nodes	percent_of_prediction	percent_of_DWPC	metapath
Loperamide—CYP2C8—Acetylsalicylic acid—Kawasaki disease	0.44	0.596	CbGbCtD
Loperamide—ABCB1—Acetylsalicylic acid—Kawasaki disease	0.298	0.404	CbGbCtD
Loperamide—POMC—neck—Kawasaki disease	0.0242	0.124	CbGeAlD
Loperamide—POMC—heart—Kawasaki disease	0.016	0.0822	CbGeAlD
Loperamide—POMC—skin of body—Kawasaki disease	0.0156	0.0805	CbGeAlD
Loperamide—CALM2—artery—Kawasaki disease	0.0118	0.061	CbGeAlD
Loperamide—CALM1—artery—Kawasaki disease	0.0118	0.0607	CbGeAlD
Loperamide—CALM2—endothelium—Kawasaki disease	0.01	0.0515	CbGeAlD
Loperamide—CALM1—endothelium—Kawasaki disease	0.00996	0.0513	CbGeAlD
Loperamide—CALM2—gall bladder—Kawasaki disease	0.00869	0.0447	CbGeAlD
Loperamide—CALM3—cardiac ventricle—Kawasaki disease	0.00846	0.0435	CbGeAlD
Loperamide—CALM3—myocardium—Kawasaki disease	0.00796	0.041	CbGeAlD
Loperamide—CALM2—cardiac ventricle—Kawasaki disease	0.00665	0.0342	CbGeAlD
Loperamide—CALM1—cardiac ventricle—Kawasaki disease	0.00662	0.034	CbGeAlD
Loperamide—CALM2—neck—Kawasaki disease	0.0066	0.034	CbGeAlD
Loperamide—CALM1—neck—Kawasaki disease	0.00657	0.0338	CbGeAlD
Loperamide—CALM2—myocardium—Kawasaki disease	0.00625	0.0322	CbGeAlD
Loperamide—CALM1—myocardium—Kawasaki disease	0.00622	0.032	CbGeAlD
Loperamide—CALM3—Synthesis of IP3 and IP4 in the cytosol—ITPKC—Kawasaki disease	0.00607	0.0885	CbGpPWpGaD
Loperamide—CALM1—Synthesis of IP3 and IP4 in the cytosol—ITPKC—Kawasaki disease	0.00587	0.0857	CbGpPWpGaD
Loperamide—CALM2—Synthesis of IP3 and IP4 in the cytosol—ITPKC—Kawasaki disease	0.00587	0.0857	CbGpPWpGaD
Loperamide—CALM3—heart—Kawasaki disease	0.00556	0.0286	CbGeAlD
Loperamide—CALM2—heart—Kawasaki disease	0.00436	0.0225	CbGeAlD
Loperamide—CALM1—heart—Kawasaki disease	0.00434	0.0223	CbGeAlD
Loperamide—CALM2—skin of body—Kawasaki disease	0.00427	0.022	CbGeAlD
Loperamide—CALM1—skin of body—Kawasaki disease	0.00425	0.0219	CbGeAlD
Loperamide—CALM3—Inositol phosphate metabolism—ITPKC—Kawasaki disease	0.00396	0.0578	CbGpPWpGaD
Loperamide—CALM2—Inositol phosphate metabolism—ITPKC—Kawasaki disease	0.00383	0.0559	CbGpPWpGaD
Loperamide—CALM1—Inositol phosphate metabolism—ITPKC—Kawasaki disease	0.00383	0.0559	CbGpPWpGaD
Loperamide—CYP2B6—heart—Kawasaki disease	0.00324	0.0167	CbGeAlD
Loperamide—CYP2B6—skin of body—Kawasaki disease	0.00318	0.0163	CbGeAlD
Loperamide—ABCB1—heart—Kawasaki disease	0.00173	0.00892	CbGeAlD
Loperamide—CALM3—Antigen activates B Cell Receptor (BCR) leading to generation of second messengers—BLK—Kawasaki disease	0.00163	0.0237	CbGpPWpGaD
Loperamide—CALM2—Antigen activates B Cell Receptor (BCR) leading to generation of second messengers—BLK—Kawasaki disease	0.00157	0.0229	CbGpPWpGaD
Loperamide—CALM1—Antigen activates B Cell Receptor (BCR) leading to generation of second messengers—BLK—Kawasaki disease	0.00157	0.0229	CbGpPWpGaD
Loperamide—POMC—Peptide ligand-binding receptors—CCR5—Kawasaki disease	0.0013	0.0189	CbGpPWpGaD
Loperamide—POMC—Metabolism—ITPKC—Kawasaki disease	0.0013	0.0189	CbGpPWpGaD
Loperamide—CACNA1A—Metabolism—ITPKC—Kawasaki disease	0.00112	0.0163	CbGpPWpGaD
Loperamide—OPRD1—Peptide GPCRs—CCR5—Kawasaki disease	0.0011	0.016	CbGpPWpGaD
Loperamide—POMC—G alpha (i) signalling events—CCR5—Kawasaki disease	0.0011	0.016	CbGpPWpGaD
Loperamide—OPRM1—IL4-mediated signaling events—IL10—Kawasaki disease	0.00103	0.0151	CbGpPWpGaD
Loperamide—OPRK1—Peptide GPCRs—CCR5—Kawasaki disease	0.000961	0.014	CbGpPWpGaD
Loperamide—POMC—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	0.000871	0.0127	CbGpPWpGaD
Loperamide—OPRM1—Peptide GPCRs—CCR5—Kawasaki disease	0.000812	0.0118	CbGpPWpGaD
Loperamide—OPRM1—TCR Signaling Pathway—CCR5—Kawasaki disease	0.000694	0.0101	CbGpPWpGaD
Loperamide—POMC—GPCR ligand binding—CCR5—Kawasaki disease	0.000663	0.00967	CbGpPWpGaD
Loperamide—CALM3—VEGFR1 specific signals—VEGFA—Kawasaki disease	0.000522	0.00762	CbGpPWpGaD
Loperamide—ABCB1—Allograft Rejection—CD40—Kawasaki disease	0.000522	0.00761	CbGpPWpGaD
Loperamide—OPRD1—Peptide ligand-binding receptors—CCR5—Kawasaki disease	0.000515	0.00752	CbGpPWpGaD
Loperamide—CALM1—VEGFR1 specific signals—VEGFA—Kawasaki disease	0.000505	0.00737	CbGpPWpGaD
Loperamide—CALM2—VEGFR1 specific signals—VEGFA—Kawasaki disease	0.000505	0.00737	CbGpPWpGaD
Loperamide—CALM3—VEGFR2 mediated cell proliferation—VEGFA—Kawasaki disease	0.00046	0.00671	CbGpPWpGaD
Loperamide—OPRK1—Peptide ligand-binding receptors—CCR5—Kawasaki disease	0.000452	0.00659	CbGpPWpGaD
Loperamide—CALM2—VEGFR2 mediated cell proliferation—VEGFA—Kawasaki disease	0.000445	0.00649	CbGpPWpGaD
Loperamide—CALM1—VEGFR2 mediated cell proliferation—VEGFA—Kawasaki disease	0.000445	0.00649	CbGpPWpGaD
Loperamide—OPRM1—TCR Signaling Pathway—CD4—Kawasaki disease	0.000436	0.00636	CbGpPWpGaD
Loperamide—OPRD1—G alpha (i) signalling events—CCR5—Kawasaki disease	0.000435	0.00634	CbGpPWpGaD
Loperamide—OPRD1—GPCRs, Class A Rhodopsin-like—CCR5—Kawasaki disease	0.000403	0.00588	CbGpPWpGaD
Loperamide—CALM3—B Cell Activation—BLK—Kawasaki disease	0.000402	0.00586	CbGpPWpGaD
Loperamide—ABCB1—Allograft Rejection—IL10—Kawasaki disease	0.0004	0.00583	CbGpPWpGaD
Loperamide—CALM2—B Cell Activation—BLK—Kawasaki disease	0.000389	0.00567	CbGpPWpGaD
Loperamide—CALM1—B Cell Activation—BLK—Kawasaki disease	0.000389	0.00567	CbGpPWpGaD
Loperamide—OPRM1—Peptide ligand-binding receptors—CCR5—Kawasaki disease	0.000382	0.00557	CbGpPWpGaD
Loperamide—OPRK1—G alpha (i) signalling events—CCR5—Kawasaki disease	0.000381	0.00556	CbGpPWpGaD
Loperamide—POMC—GPCR downstream signaling—CCR5—Kawasaki disease	0.000375	0.00547	CbGpPWpGaD
Loperamide—OPRK1—GPCRs, Class A Rhodopsin-like—CCR5—Kawasaki disease	0.000354	0.00516	CbGpPWpGaD
Loperamide—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	0.000346	0.00504	CbGpPWpGaD
Loperamide—POMC—Signaling by GPCR—CCR5—Kawasaki disease	0.00034	0.00496	CbGpPWpGaD
Loperamide—OPRM1—G alpha (i) signalling events—CCR5—Kawasaki disease	0.000322	0.0047	CbGpPWpGaD
Loperamide—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	0.000303	0.00442	CbGpPWpGaD
Loperamide—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—Kawasaki disease	0.000299	0.00436	CbGpPWpGaD
Loperamide—CALM1—Endochondral Ossification—MMP9—Kawasaki disease	0.000299	0.00436	CbGpPWpGaD
Loperamide—CALM2—Endochondral Ossification—MMP9—Kawasaki disease	0.000299	0.00436	CbGpPWpGaD
Loperamide—CALM2—Endochondral Ossification—VEGFA—Kawasaki disease	0.000268	0.00391	CbGpPWpGaD
Loperamide—CALM1—Endochondral Ossification—VEGFA—Kawasaki disease	0.000268	0.00391	CbGpPWpGaD
Loperamide—CALM3—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—Kawasaki disease	0.000264	0.00385	CbGpPWpGaD
Loperamide—OPRD1—GPCR ligand binding—CCR5—Kawasaki disease	0.000263	0.00384	CbGpPWpGaD
Loperamide—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—Kawasaki disease	0.000256	0.00374	CbGpPWpGaD
Loperamide—CALM2—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—Kawasaki disease	0.000255	0.00373	CbGpPWpGaD
Loperamide—CALM1—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—Kawasaki disease	0.000255	0.00373	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—ITPKC—Kawasaki disease	0.000243	0.00354	CbGpPWpGaD
Loperamide—CALM3—Metabolism—ITPKC—Kawasaki disease	0.000236	0.00344	CbGpPWpGaD
Loperamide—CALM3—Platelet degranulation—VEGFA—Kawasaki disease	0.000232	0.00338	CbGpPWpGaD
Loperamide—OPRK1—GPCR ligand binding—CCR5—Kawasaki disease	0.000231	0.00337	CbGpPWpGaD
Loperamide—CALM2—Metabolism—ITPKC—Kawasaki disease	0.000228	0.00333	CbGpPWpGaD
Loperamide—CALM1—Metabolism—ITPKC—Kawasaki disease	0.000228	0.00333	CbGpPWpGaD
Loperamide—CALM2—Platelet degranulation—VEGFA—Kawasaki disease	0.000224	0.00327	CbGpPWpGaD
Loperamide—CALM1—Platelet degranulation—VEGFA—Kawasaki disease	0.000224	0.00327	CbGpPWpGaD
Loperamide—CALM3—Response to elevated platelet cytosolic Ca2+—VEGFA—Kawasaki disease	0.000221	0.00322	CbGpPWpGaD
Loperamide—CALM1—Response to elevated platelet cytosolic Ca2+—VEGFA—Kawasaki disease	0.000214	0.00312	CbGpPWpGaD
Loperamide—CALM2—Response to elevated platelet cytosolic Ca2+—VEGFA—Kawasaki disease	0.000214	0.00312	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—ITPKC—Kawasaki disease	0.000205	0.00299	CbGpPWpGaD
Loperamide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—Kawasaki disease	0.000205	0.00299	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—CCR5—Kawasaki disease	0.000201	0.00293	CbGpPWpGaD
Loperamide—OPRM1—GPCR ligand binding—CCR5—Kawasaki disease	0.000195	0.00284	CbGpPWpGaD
Loperamide—CALM3—VEGFA-VEGFR2 Pathway—VEGFA—Kawasaki disease	0.000184	0.00268	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—ITPKC—Kawasaki disease	0.000179	0.00261	CbGpPWpGaD
Loperamide—CALM1—VEGFA-VEGFR2 Pathway—VEGFA—Kawasaki disease	0.000178	0.00259	CbGpPWpGaD
Loperamide—CALM2—VEGFA-VEGFR2 Pathway—VEGFA—Kawasaki disease	0.000178	0.00259	CbGpPWpGaD
Loperamide—ABCB1—Allograft Rejection—VEGFA—Kawasaki disease	0.000178	0.00259	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—FCGR2A—Kawasaki disease	0.000174	0.00254	CbGpPWpGaD
Loperamide—CALM3—Signaling by VEGF—VEGFA—Kawasaki disease	0.000173	0.00253	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—ITPKC—Kawasaki disease	0.000169	0.00246	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—FCGR2A—Kawasaki disease	0.000168	0.00245	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—FCGR2A—Kawasaki disease	0.000168	0.00245	CbGpPWpGaD
Loperamide—CALM1—Signaling by VEGF—VEGFA—Kawasaki disease	0.000168	0.00245	CbGpPWpGaD
Loperamide—CALM2—Signaling by VEGF—VEGFA—Kawasaki disease	0.000168	0.00245	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—BLK—Kawasaki disease	0.000162	0.00236	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—BLK—Kawasaki disease	0.000157	0.00229	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—BLK—Kawasaki disease	0.000157	0.00229	CbGpPWpGaD
Loperamide—OPRD1—GPCR downstream signaling—CCR5—Kawasaki disease	0.000149	0.00217	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—CCR5—Kawasaki disease	0.000135	0.00197	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—CD40—Kawasaki disease	0.000135	0.00196	CbGpPWpGaD
Loperamide—OPRK1—GPCR downstream signaling—CCR5—Kawasaki disease	0.00013	0.0019	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—CD40—Kawasaki disease	0.00013	0.0019	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—CD40—Kawasaki disease	0.00013	0.0019	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—CCR5—Kawasaki disease	0.000118	0.00173	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—CCR5—Kawasaki disease	0.00011	0.00161	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—ITPKC—Kawasaki disease	0.00011	0.00161	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—MMP9—Kawasaki disease	0.00011	0.0016	CbGpPWpGaD
Loperamide—CALM3—Platelet activation, signaling and aggregation—VEGFA—Kawasaki disease	0.000103	0.0015	CbGpPWpGaD
Loperamide—CALM3—Immune System—FCGR2A—Kawasaki disease	0.000101	0.00148	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—CCR5—Kawasaki disease	0.0001	0.00146	CbGpPWpGaD
Loperamide—CALM2—Platelet activation, signaling and aggregation—VEGFA—Kawasaki disease	9.95e-05	0.00145	CbGpPWpGaD
Loperamide—CALM1—Platelet activation, signaling and aggregation—VEGFA—Kawasaki disease	9.95e-05	0.00145	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—VEGFA—Kawasaki disease	9.87e-05	0.00144	CbGpPWpGaD
Loperamide—CALM3—Immune System—BLK—Kawasaki disease	9.83e-05	0.00143	CbGpPWpGaD
Loperamide—CALM2—Immune System—FCGR2A—Kawasaki disease	9.8e-05	0.00143	CbGpPWpGaD
Loperamide—CALM1—Immune System—FCGR2A—Kawasaki disease	9.8e-05	0.00143	CbGpPWpGaD
Loperamide—CALM2—Immune System—BLK—Kawasaki disease	9.51e-05	0.00139	CbGpPWpGaD
Loperamide—CALM1—Immune System—BLK—Kawasaki disease	9.51e-05	0.00139	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—CRP—Kawasaki disease	9.04e-05	0.00132	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Kawasaki disease	8.76e-05	0.00128	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—CRP—Kawasaki disease	8.74e-05	0.00127	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—CRP—Kawasaki disease	8.74e-05	0.00127	CbGpPWpGaD
Loperamide—CALM3—Immune System—CD40—Kawasaki disease	8.17e-05	0.00119	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—CCR5—Kawasaki disease	7.98e-05	0.00116	CbGpPWpGaD
Loperamide—CALM1—Immune System—CD40—Kawasaki disease	7.9e-05	0.00115	CbGpPWpGaD
Loperamide—CALM2—Immune System—CD40—Kawasaki disease	7.9e-05	0.00115	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—CCR5—Kawasaki disease	7e-05	0.00102	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—CCR5—Kawasaki disease	6.2e-05	0.000904	CbGpPWpGaD
Loperamide—CALM3—Innate Immune System—CD4—Kawasaki disease	6.1e-05	0.00089	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—CCR5—Kawasaki disease	5.99e-05	0.000874	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—CCR5—Kawasaki disease	5.99e-05	0.000874	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—CCR5—Kawasaki disease	5.91e-05	0.000862	CbGpPWpGaD
Loperamide—CALM1—Innate Immune System—CD4—Kawasaki disease	5.9e-05	0.000861	CbGpPWpGaD
Loperamide—CALM2—Innate Immune System—CD4—Kawasaki disease	5.9e-05	0.000861	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—CD4—Kawasaki disease	5.86e-05	0.000855	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—CD4—Kawasaki disease	5.67e-05	0.000827	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—CD4—Kawasaki disease	5.67e-05	0.000827	CbGpPWpGaD
Loperamide—CALM3—Hemostasis—VEGFA—Kawasaki disease	5.3e-05	0.000773	CbGpPWpGaD
Loperamide—CALM3—Immune System—CRP—Kawasaki disease	5.26e-05	0.000768	CbGpPWpGaD
Loperamide—CALM3—Disease—CCR5—Kawasaki disease	5.23e-05	0.000762	CbGpPWpGaD
Loperamide—CALM1—Hemostasis—VEGFA—Kawasaki disease	5.13e-05	0.000748	CbGpPWpGaD
Loperamide—CALM2—Hemostasis—VEGFA—Kawasaki disease	5.13e-05	0.000748	CbGpPWpGaD
Loperamide—CALM1—Immune System—CRP—Kawasaki disease	5.09e-05	0.000743	CbGpPWpGaD
Loperamide—CALM2—Immune System—CRP—Kawasaki disease	5.09e-05	0.000743	CbGpPWpGaD
Loperamide—CALM2—Disease—CCR5—Kawasaki disease	5.06e-05	0.000737	CbGpPWpGaD
Loperamide—CALM1—Disease—CCR5—Kawasaki disease	5.06e-05	0.000737	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—MMP9—Kawasaki disease	4.36e-05	0.000636	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—VEGFA—Kawasaki disease	3.92e-05	0.000571	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—MMP9—Kawasaki disease	3.83e-05	0.000558	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—CCR5—Kawasaki disease	3.66e-05	0.000534	CbGpPWpGaD
Loperamide—CALM3—Immune System—CD4—Kawasaki disease	3.56e-05	0.000519	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—CCR5—Kawasaki disease	3.54e-05	0.000516	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—CCR5—Kawasaki disease	3.54e-05	0.000516	CbGpPWpGaD
Loperamide—CALM1—Immune System—CD4—Kawasaki disease	3.44e-05	0.000502	CbGpPWpGaD
Loperamide—CALM2—Immune System—CD4—Kawasaki disease	3.44e-05	0.000502	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—VEGFA—Kawasaki disease	3.44e-05	0.000501	CbGpPWpGaD
Loperamide—CALM3—Disease—CD4—Kawasaki disease	3.28e-05	0.000479	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—MMP9—Kawasaki disease	3.23e-05	0.000472	CbGpPWpGaD
Loperamide—CALM1—Disease—CD4—Kawasaki disease	3.18e-05	0.000463	CbGpPWpGaD
Loperamide—CALM2—Disease—CD4—Kawasaki disease	3.18e-05	0.000463	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—VEGFA—Kawasaki disease	2.9e-05	0.000424	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—MMP9—Kawasaki disease	2e-05	0.000292	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—MMP9—Kawasaki disease	1.94e-05	0.000282	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—MMP9—Kawasaki disease	1.94e-05	0.000282	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—VEGFA—Kawasaki disease	1.8e-05	0.000262	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—VEGFA—Kawasaki disease	1.74e-05	0.000254	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—VEGFA—Kawasaki disease	1.74e-05	0.000254	CbGpPWpGaD
